Investment Information

With transparent disclosure of information and communication with markets,
we will grow along with shareholders.

Disclosures & Reports

Public Disclosures

NO Title Date Submission Obligator
10 [Revised]An Explanation for Rumors or Media Reports 2020/01/22 HANALL BIOPHARMA CO.,LTD
9 An Explanation for Rumors or Media Reports 2020/01/22 HANALL BIOPHARMA CO.,LTD
8 Designation of overheated short-selling issues (applied by a restriction on short-selling) 2020/01/21 HANALL BIOPHARMA CO.,LTD
7 30% or More Changes in Sales or Profits/Losses (15% or More in the case of Large-scale Corporations) 2020/01/16 HANALL BIOPHARMA CO.,LTD
6 Interim Report on Business Performance(Fair Disclosure) 2020/01/16 HANALL BIOPHARMA CO.,LTD
5 Material Management Information related to Judgment of Investment 2020/01/08 HANALL BIOPHARMA CO.,LTD
4 Material Management Information related to Judgment of Investment 2019/12/20 HANALL BIOPHARMA CO.,LTD
3 Closure of Stock Transfer (Shareholder's Registry) 2019/12/16 HANALL BIOPHARMA CO.,LTD
2 Organization of Investor Relations Event 2019/10/31 HANALL BIOPHARMA CO.,LTD
1 Interim Report on Business Performance(Fair Disclosure) 2019/10/28 HANALL BIOPHARMA CO.,LTD

Electronic Announcement

공시정보 전자공고 목록
NO Title Date Related Data
2 2018 Statement of financial position 2019-03-22
1 2017 Statement of financial position 2018-03-30

Management Regulation on Public Announcement

공시정보 전자공고 목록
NO Title Date Related Data
1 Management Regulation on Public Announcement 2009-08-31